Technologies

West Yorkshire Continuous Glucose Monitoring (CGM) Implementation Plan Position Statement August 2024

The West Yorkshire Continuous Glucose Monitoring (CGM) Implementation Plan Position Statement provides a strategic update on our 5-year roll out plan for CGM (and hybrid closed loop (HCL). It aims to address concerns and refocus on the cost-effectiveness of this healthcare intervention, while ensuing a structured and controlled continuation of the technology rollout empowering people with diabetes and improving health outcomes. 

Continuous glucose monitoring (CGM)

Continuous glucose monitoring (CGM) is be available on the NHS to anyone with type 1 diabetes in West Yorkshire. Some people with type 2 diabetes may also be offered a CGM to help manage diabetes.

Children and young people will usually be offered CGM. 

You can view and download all continuous glucose monitoring-related information through the following link: Medicines information :: West Yorkshire Health & Care Partnership (wypartnership.co.uk)

West Yorkshire Continuous Glucose Monitoring (CGM) Pathway for Primary Care

This is a West Yorkshire CGM pathway for primary care - drawn up to support the implementation of CGM for those eligible with type 2 diabetes (and those with type 1 diabetes choosing to have their diabetes care and support provided through primary care rather than specialist diabetes teams in secondary care). Author of the pathway, Dr Waqas Tahir, WY ICS Diabetes Clinical Lead, said:
"This pathway aims to guide best practice by providing a consistent, evidence-based approach for clinicians. It consolidates essential guidance into a single document, supporting healthcare professionals in making informed, autonomous decisions when initiating eligible individuals on the technology. By following this pathway, clinicians can ensure that their actions are aligned with the highest standards of care, promoting safety, efficacy and patient-centred outcomes."

Frequently asked questions (FAQs) on diabetes med-technology

• FAQs on Diabetes med-technology for our WY Diabetes Workforce & Clinicians
• Identifying patients and switching from Freestyle Libre 2 to Freestyle Libre 2 PLUS

The Wakefield CGM implementation strategy Dec 2023

This communication about the Wakefield CGM implementation strategy is specific to Wakefield only. It is designed to align the implementation of NICE guidance for both type 1 and type 2 diabetes in Wakefield Place with the WYCGM commission policy and implementation strategy. A copy of the December 2023 Wakefield CGM implementation strategy is also available as a separate document.

• Training

  Webinars

• West Yorkshire Diabetes Med-tech Data Blue Print: A Solution Focused Workshop 

NHSE hybrid-closed loop systems (HCL) Guidance and Resources

NHS England’s strategic finance team have produced guidance for ICBs and NHS trusts on HCL technologies reimbursement fund.

• WY ICB HCL Delivery Plans NHSE Feedback Letter
• ICB HCL good  practice examples
• NHSE NDA HCL Specialist Services Letter April 2024
• NHSE mylife YpsoPump digital essentials pack
• Further patient facing information about hybrid-closed loop systems has now been published on the NHS England and NHS.UK web pages.

• The NHS England HCL webpage now includes more information for members of the public about the benefits of HCL, who is eligible and how it will be made available across the NHS in England.

• NHS England » Implementation of hybrid-closed loop technologies in England: information for people living with type 1 diabetes and their carers
• The Type 1 diabetes information pages within the NHS Health A-Z were refreshed in October 2024 and now include information on hybrid-closed loops and provide details on who it is suitable for and the phased roll out. The NHS Health A-Z provides accessible information to the public about health conditions, symptoms and treatments and is a first port of call for many members of the public.

• Frequently asked questions (FAQs) on diabetes med-technology

• NHS England FAQs HCL:  Implementing the 5 Year Strategy Feb 2024
• FAQs on Diabetes med-technology for our WY Diabetes Workforce & Clinicians

• Webinars

• West Yorkshire Diabetes Med-tech Data Blue Print: A Solution Focused Workshop 

• Treatment for type 1 diabetes - NHS

• Decision support tool: making a decision about managing type 1 diabetes

  The new decision support tool has been designed to support people to understand what is available in the NHS, providing a resource to support discussions between someone living with type 1 diabetes and their healthcare professional about appropriate steps in their care, which they are eligible for and come to a shared decision about the person’s care in managing type 1 diabetes. Download the tool and share with your patient(s).

• Minuteful Kidney: Digitally Enabled Home Testing for Microalbuminuria

  The Minuteful Kidney test – Healthy.io –solution consists of a uACR home testing kit delivered to patient’s registered home address by Healthy.io and used with a patient’s smartphone and a free downloadable application/app.  Patients with hypertension who would otherwise be required to attend a GP clinic for traditional uACR testing will be provided with a quick, easy, safe, and convenient alternative to ‘in clinic’ uACR tests.  This in turn will support practices to reduce the backlog of untested patients with hypertension whilst supporting individuals/patients who may otherwise be disengaged with their GP for traditional testing methods. More information on the WY ICB Kidney Health page